Peter Staib

20.3k citations
135 papers · 5.8k indexed · 2 hit papers · h-index 42

Peter Staib

131 papers receiving 5.7k citations

Hit Papers

Neoadjuvant ...1362002202620102018200400600

Peers

Peter Staib
Comparison fields: 5 of 130
  • Hematology 2.2k
  • Genetics 1.4k
  • Infectious Diseases 1.0k
  • Oncology 1.0k
  • Pathology and Forensic Medicine 635
Replace Gary J. Schiller with:
Gary J. Schiller United States
Günther Gastl Austria
Pier Luigi Tazzari Italy
Koji Kato Japan
Kanjaksha Ghosh India
Suradej Hongeng Thailand
Gösta Gahrton Sweden
Anders Sundan Norway
Nathalie Dhédin France
Ephraim J. Fuchs United States
Peter Staib relative to Gary J. Schiller United States Gary J. Schiller's profile →
Citations per field
00.5×1.5×
Gary J. Schiller · 1×
Citations per year

Countries citing papers authored by Peter Staib

Since Specialization
Citations

This map shows the geographic impact of Peter Staib's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Staib with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Staib more than expected).

Fields of papers citing papers by Peter Staib

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Staib. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Staib. The network helps show where Peter Staib may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Peter Staib, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter Staib Line = papers co-authored together Peter Staib links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2 20236
3 20230
4 20233
5 20184
6 201536
7 201322
8 201111
9 201133
10 201092
11 2008232
12 20054
13 20053
14 200519
15 20056
16 200241
17 200121
18 200022
19 199955
20 1999109

About Peter Staib

Peter Staib is a scholar working on Hematology, Genetics and Infectious Diseases, having authored 135 papers that have together received 5.8k indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (29 papers), Acute Myeloid Leukemia Research (26 papers), Fungal Infections and Studies (23 papers), Chronic Lymphocytic Leukemia Research (16 papers), Chronic Myeloid Leukemia Treatments (13 papers), Acute Lymphoblastic Leukemia research (13 papers), Nail Diseases and Treatments (12 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (11 papers). The work is most often cited by research in Hematology (2.2k citations), Genetics (1.4k citations) and Infectious Diseases (1.0k citations). Peter Staib has collaborated with scholars based in Germany, Switzerland and Belgium. Frequent co-authors include Joachim Morschhäuser, Torsten Haferlach, Wolfgang Kern, Susanne Schnittger, Hubert Serve, Thomas Büchner, Michel Monod, Claudia Schoch, Wolfgang Hiddemann and Helmut Löffler. Their work appears in journals such as Journal of Clinical Oncology, Blood, Annals of Oncology, International Journal of Cosmetic Science and Molecular Microbiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026